Identifying colorectal cancer patients in South Africa who may not seek oncology care
A clinical prediction rule for identifying South African colorectal cancer patients who will fail to engage in oncology care
This study is looking to find out which new colorectal cancer patients in South Africa might have trouble getting the treatment they need, so doctors can better support those who need extra help.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kwazulu-Natal NIH-funded |
| Lab location | 1 site (Durban, South Africa) |
| Project ID | NIH-10919199 on NIH RePORTER |
What this research studies
This research aims to develop a clinical prediction rule to identify newly diagnosed colorectal cancer patients in South Africa who are at high risk of failing to engage in oncology care. By analyzing data from a cohort of patients and utilizing machine learning techniques, the study seeks to pinpoint specific predictors that indicate which patients may struggle to access necessary treatment. This targeted approach will help healthcare providers focus their resources on those who need it most, improving overall patient management in a resource-constrained environment.
Who could benefit from this research
Good fit: Ideal candidates for this research are newly diagnosed colorectal cancer patients in South Africa, particularly those in the public healthcare sector.
Not a fit: Patients who are not newly diagnosed with colorectal cancer or those already engaged in oncology care may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to oncology care for high-risk colorectal cancer patients in South Africa.
How similar studies have performed: Similar approaches using clinical prediction rules have shown promise in other healthcare settings, indicating potential for success in this novel application.
Where this research is happening
Durban, South Africa
- University of Kwazulu-Natal — Durban, South Africa (Active)
Researchers
- Principal investigator: Moodley, Yoshan — University of Kwazulu-Natal
- Study coordinator: Moodley, Yoshan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.